Geometry of volumes in radiotherapy planning. A new method for a quantitative assessment

Tumori

Volumn 97, Issue 4, 2011, Pages 503-509

  Tomatis, Stefano ^a   Carrara, Mauro ^a   Massafra, Elisa ^b   Naldi, Giovanni ^b   Palazzi, Mauro ^c   Orlandi, Ester ^a   Marchesini, Renato ^b  

^a NATIONAL CANCER INSTITUTE   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c OSPEDALE NIGUARDA CA GRANDA   (Italy)

Author keywords

Geometrical features; Quantification; Radiotherapy volumes; Treatment plan optimization

Indexed keywords

ARTICLE; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER PROGRAM; CONTROLLED STUDY; DIGITAL IMAGING AND COMMUNICATIONS IN MEDICINE; EXPANSION INTERSECTION HISTOGRAM; GEOMETRY; HISTOGRAM; PHANTOM; QUANTITATIVE ANALYSIS; TARGET ORGAN; TREATMENT PLANNING; TUMOR VOLUME;

EID: 80053623777     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/030089161109700415     Document Type: Article

References (18)

1. Connell PP, Hellman S: Advances in radiotherapy and implications for the next century: a historical perspective. Cancer Res, 69: 383-392, 2009.
2. Nystrom H, Thwaites DI: Physics and high-technology advances in radiotherapy: are they still worth it? Radiother Oncol, 86: 1-3, 2008.
3. Kubicek GJ, Machtay M: New advances in high-technology radiotherapy for head and neck cancer. Hematol Oncol Clin N, 22: 1165-1180, 2008.
4. Schubert LK, Westerly DC, Tomè WA, Mehta MP, Soisson ET, Mackie TR, Ritter MA, Khuntia D, Harari PM, Paliwal BR: A comprehensive assessment by tumor site of patient setup using daily MVCT imaging frommore than 3,800 helical tomotherapy treatments. Int J Radiat Oncol Biol Phys, 73: 1260-1269, 2009.
5. Haasbeek CJA, Slotman BJ, Senan S: Radiotherapy for lung cancer: clinical impact of recent technical advances. Lung Cancer, 64: 1-8, 2009.
6. Fenwick JD, Tomé WA, Soisson ET, Mehta MP, Mackie TR: Tomotherapy and other innovative IMRT delivery systems. Semin Radiat Oncol, 16: 199-208, 2006. (Pubitemid 44436960)
7. Deza E, Deza MM: Dictionary of Distances, 1st ed, Elsevier, Amsterdam, 2006.
8. Oosterwijk H, Gihring PT: DICOM Basics, 3rd ed, OTech Inc, Aubrey (TX), 2002.
9. Stroom JC, Storchi PRM: Automatic calculation of three-dimensional margins around treatment volumes in radiotherapy planning. Phys Med Biol, 42: 745-755, 1997. (Pubitemid 27195906)
10. Belshi R, Pontvert D, Rosenwald JC, Gaboriaud G: Automatic three-dimensional expansion of structures applied to determination of the clinical target volume in conformal radiotherapy. Int J Radiat Oncol Biol Phys, 37: 689-696, 1997. (Pubitemid 27175324)
11. Pooler AM, Mayles HM, Naismith OF, Sage JP, Dearnaley DP: Evaluation of margining algorithms in commercial treatment planning systems. Radiother Oncol, 86: 43-47, 2008.
12. Van Dyk J: Quality assurance of radiation therapy planning systems: current status and remaining challenges. Int J Radiat Oncol Biol Phys, 71 (Suppl 1): S23-S27, 2008.
13. Fraass B, Doppke K, Hunt M, Kutcher G, Starkschall G, Stern R, Van Dyk J: American Association of Physicists in Medicine Radiation Therapy Committee Task Group 53: Quality assurance for clinical radiotherapy treatment planning. Med Phys, 25: 1773-1829, 1998. (Pubitemid 28485202)
14. International Atomic Energy Agency, IAEA: Commissioning and quality assurance of computerized planning systems for radiation treatment of cancer: IAEA TRS-430. International Atomic Energy Agency, Vienna, 2004.
15. Radiation Therapy Oncology Group (RTOG) available at: http://www.rtog.org.
16. Hunt MA, Jackson A, Narayana A, Lee N: Geometric factors influencing dosimetric sparing of the parotid glands using IMRT. Int J Rad Oncol Biol Phys, 66: 296-304, 2006. (Pubitemid 44175676)
17. Chau RMC, Leung SF, Kam MKM, Cheung KY, Kwan WH, Yu KH, Chiu KW, Cheung MLM, Chan ATC: A broadly adaptive array of dose-constraint templates for planning of intensity- modulated radiation therapy for advanced t-stage nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys, 74: 21-28, 2009.
18. Gluck I, Vineberg KA, Haken RKT, Sandler HM: Evaluating the relationships between rectal normal tissue complication probability and the portion of seminal vesicles included in the clinical target volume in intensity-modulated radiotherapy for prostate cancer. Int J Radiat Oncol Biol Phys, 73: 334-340, 2009.